Tech Company Financing Transactions

Xenocor Funding Round

Xenocor closed a $10 million Series A financing round on 4/18/2023. Backers included Baranco Investments, Barvest Ventures and GenHenn Venture.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
The company intends to use the funds for the 2023 launch of the Saberscope and to continue executing on its innovation roadmap.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
350 East 400 South 401
Salt Lake City, UT 84111
Email Address
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Xenocor LinkedIn Company Profile
Social Media
Xenocor Company Twitter Account
Company News
Xenocor News
Xenocor on Facebook
Xenocor on YouTube

Management Team

Email & Social
Chief Executive Officer
Charles DeCoste
  Charles DeCoste LinkedIn Profile  Charles DeCoste Twitter Account  Charles DeCoste News  Charles DeCoste on Facebook
Chief Operating Officer
Tony Watson
  Tony Watson LinkedIn Profile  Tony Watson Twitter Account  Tony Watson News  Tony Watson on Facebook
Chief Technical Officer
Lane Brooks
  Lane Brooks LinkedIn Profile  Lane Brooks Twitter Account  Lane Brooks News  Lane Brooks on Facebook



Browse more venture capital transactions:

Prev: 4/18/2023: Volumez venture capital transaction
Next: 4/18/2023: SpecterOps venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary